Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals

27 de octubre de 2021 actualizado por: University Hospital, Basel, Switzerland

Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services

Heads of all psychosomatic, psychiatric and psychological consultation and liaison (C&L) services in acute care hospitals across all participating countries will be contacted and asked to participate in this international cross-sectional online survey. The survey consists of questions about care structures and their utilisation that psychosomatic, psychiatric and psychological C&L services have established in acute hospitals in the context of the COVID 19 pandemic.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Descripción detallada

Background:

The COVID-19 pandemic raised new challenges in supporting patients, relatives and staff for psychosomatic, psychiatric and psychological C&L services in general hospitals worldwide. It is intended to build upon the experience gained so far in order to be well prepared for the future.

Objectives:

The aims of this international online survey are

  1. To summarize the efforts made in psychosocial care in the context of the COVID-19 pandemic.
  2. To assess the experiences made with the established services so far.
  3. To assess the need for networking, cooperation and support.
  4. Improvement of psychosocial care in acute hospitals in the context of pandemics.

Study Design:

This health services research project will be carried out as an observational study in the form of an international cross-sectional online survey.

There will be one survey time point. Study reporting will follow the STROBE Statement (Strengthening the Reporting of Observational Studies in Epidemiology).

Ethic approval:

In all participating countries the respective ethics committees were informed about the survey and it was checked with them, how far and what kind of country-specific vote of an ethics committee was necessary. Written statements, declarations or votes were obtained from all participating countries.

Setting:

The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries are contacted and asked to participate. Contact is made via the respective national professional societies and relevant working and interest groups.

Participants This study is an international online survey with psychosomatic, psychiatric and psychological C&L services from 14 European countries (Austria, Belgium, Finland, Germany, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom) as well as parts of Canada (Quebec and Ontario region) and Iran participating.

Country specific regions:

The national coordinators of the participating country provided lists of specific regions for their respective country following the NUTS logic (Nomenclature of Territorial Units for Statistics; https://en.wikipedia.org/wiki/Nomenclature_of_Territorial_Units_for_Statistics), preferably a NUTS level that leads to 5 - 20 NUTS for each country.

Online survey questionnaire:

Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding characterization of the participating C&L services, involvement of the respective hospitals in the physical care of COVID-19 patients, structures / organization of psychosocial care for COVID-19 patients in the participating hospitals, specific psychosocial support for patients, relatives and staff established in the participating hospital in the context of COVID-19, communication - How the different target groups were informed about the COVID-19 related psychosocial support services and offers, burden of the COVID-19 pandemic on the psychosocial C&L teams, needs and wishes for the future.

The study questionnaire was translated by a professional company from German into English, French and Italian. Language harmonization and cultural adaptation followed a modified committee-based approach informed by the European Social Survey (ESS) Round 9 Translation Guidelines. Participants are free to choose the language version to be worked on.

Tipo de estudio

De observación

Inscripción (Actual)

230

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Bayern
      • Nürnberg, Bayern, Alemania, 90419
        • Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy
    • Nordrhein-Westfalen
      • Köln, Nordrhein-Westfalen, Alemania, 50937
        • University Hospital Cologne, Department of Psychosomatics and Psychotherapy
    • Steiermark
      • Graz, Steiermark, Austria, 8036
        • Medical University of Graz, University Hospital Graz
      • Ghent, Bélgica
        • Ghent University Hospital, Department of Psychiatry
      • Montreal, Canadá
        • University of Montreal, Department of Psychosomatic Medicine
      • Toronto, Canadá
        • TorontoSinai Health, University of Toronto, Department of Psychiatry
      • Barcelona, España
        • Barcelona University
      • Oulu, Finlandia, 90220
        • Oulu University Hospital and University of Oulu
      • Paris, Francia
        • Université de Paris, Service de Psychiatrie de l'adulte
      • Thessaloniki, Grecia
        • Aristotle University Thessaloniki
      • Dublin, Irlanda
        • University College Dublin
      • Tehran, Irán (República Islámica de
        • University of Medical Sciences, Department of Psychiatry
      • Bologna, Italia, 40123
        • Bologna University
      • Modena, Italia, 411274
        • University of Modena & Reggio Emilia
      • Oslo, Noruega
        • Oslo University Hospital
      • Wroclaw, Polonia
        • Wroclaw Medical University
      • Lisboa, Portugal
        • Hospital de Santa Maria
      • Lisboa, Portugal
        • Universidade Católica Portuguesa Lisboa
      • Exeter, Reino Unido
        • University of Exeter
      • York, Reino Unido
        • University of York
      • Basel, Suiza, 4002
        • University of Basel, Department of Psychiatry (UPK)
    • Basel-City
      • Basel, Basel-City, Suiza, 4031
        • University Hospital Basel, Department of Psychosomatic Medicine

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries will be contacted and asked to participate. Contact will be made via the respective national professional societies and relevant working and interest groups

Descripción

Inclusion Criteria:

  • heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries

Exclusion Criteria:

  • None

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Structural and process quality of COVID-19 related psychosocial C&L services
Periodo de tiempo: 6 months

Data basis for improving quality of COVID-19 related psychosocial C&L services:

  1. characterization of participating C&L services
  2. involvement of respective hospitals in the physical care of COVID-19 patients
  3. structures/ organization of psychosocial care for COVID-19 patients in participating hospitals
  4. specific psychosocial support established in participating hospitals in context of COVID-19 for

    1. patients
    2. relatives
    3. staff
  5. communication strategies - How the different target groups were informed about COVID-19 related psychosocial support services and offers
  6. burden of COVID-19 pandemic on psychosocial C&L teams
  7. needs and wishes of the participating psychosocial C&L services

    1. for support or exchange of experience regarding psychosocial care in the COVID 19 context
    2. for changes / improvements considered essential for the future with regard to psychosocial care services in the participating hospitals in the COVID-19 context
6 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Rainer Schaefert, Prof. Dr. med., University Hospital, Basel, Switzerland

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

8 de diciembre de 2020

Finalización primaria (Actual)

3 de octubre de 2021

Finalización del estudio (Actual)

3 de octubre de 2021

Fechas de registro del estudio

Enviado por primera vez

11 de febrero de 2021

Primero enviado que cumplió con los criterios de control de calidad

11 de febrero de 2021

Publicado por primera vez (Actual)

15 de febrero de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

28 de octubre de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

27 de octubre de 2021

Última verificación

1 de octubre de 2021

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir